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ABSTRACT 
Background 
Case studies and anecdotal reports have documented a range of acute illnesses associated 
with exposure to cyanobacteria and their toxins in recreational waters. The 
epidemiological data to date is limited; we sought to improve on the design of some 
previously conducted studies in order to facilitate revision and refinement of guidelines 
for exposure to cyanobacteria in recreational waters. 
 
Methods  
A prospective cohort study was conducted to investigate the incidence of acute symptoms 
in individuals exposed, through recreational activities, to low (cell surface area 
<2.4mm2/mL), medium (2.4–12.0mm2/mL) and high (>12.0mm2/mL) levels of 
cyanobacteria in lakes and rivers in southeast Queensland, the central coast area of New 
South Wales, and northeast and central Florida. Multivariable logistic regression analyses 
were employed; models adjusted for region, age, smoking, prior history of asthma, hay 
fever or skin disease (eczema or dermatitis) and clustering by household.  
 
Results 
Of individuals approached, 3,595 met the eligibility criteria, 3,193 (89%) agreed to 
participate and 1,331 (37%) completed both the questionnaire and follow-up interview. 
Respiratory symptoms were 2.1 (95% CI: 1.1, 4.0) times more likely to be reported by 
subjects exposed to high levels of cyanobacteria than by those exposed to low levels. 
Similarly, when grouping all reported symptoms, individuals exposed to high levels of 
cyanobacteria were 1.7 (95% CI: 1.0, 2.8) times more likely to report symptoms than 
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their low-level cyanobacteria-exposed counterparts. While the effect sizes for the 
reporting of ear symptoms, skin symptoms and fever between high and low exposure 
groups were similar to those for respiratory and pooled symptoms, the observed 
frequencies were small and thus the differences between exposure groups were not 
statistically significant.  
 
Conclusions  
A significant increase in reporting of minor self-limiting symptoms, particularly 
respiratory symptoms, was associated with exposure to higher levels of cyanobacteria of 
mixed genera. We suggest that exposure to cyanobacteria based on total surface area 
above 12 mm2/mL could result in increased incidence of symptoms. The potential for 
severe, life-threatening cyanobacteria-related illness is likely to be greater in recreational 
waters that have significant levels of cyanobacterial toxins, so future epidemiological 
investigations should be directed towards recreational exposure to cyanotoxins. 
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BACKGROUND 
 
Planktonic cyanobacteria are common inhabitants of freshwater lakes and reservoirs 
throughout the world. Under favourable conditions, certain cyanobacteria can dominate 
the phytoplankton within a waterbody and form nuisance blooms. The principal public 
health concern regarding exposure to freshwater cyanobacteria relates to the 
understanding that some blooms produce toxins that specifically affect the liver or the 
central nervous system. Exposure routes for systemic poisoning by these toxins are oral, 
from accidental or deliberate ingestion of recreational water, and possibly by inhalation.  
 
A small collection of case reports and anecdotal references dating from 1949 have 
described a range of illnesses associated with recreational exposure to cyanobacteria: hay 
fever-like symptoms, pruritic skin rashes and gastro-intestinal symptoms are most 
frequently reported. Some papers give convincing descriptions of allergic responses to 
cyanobacteria; others describe more serious acute illnesses, with symptoms such as 
severe headache, pneumonia, fever, myalgia, vertigo and blistering in the mouth. 
Anecdotal and case reports and the epidemiology of recreational exposure to freshwater 
cyanobacteria were recently reviewed by Stewart et al [1]. Under-reporting of minor, self-
limiting illnesses may explain the small number of anecdotal and case reports in the 
literature. Moreover, a knowledge gap about cyanobacteria probably exists for many 
primary health care providers. Epidemiological studies into recreational exposure to 
cyanobacteria are also few in number. Five have been published to date: three cross-
sectional studies from the United Kingdom using identical survey instruments [2-4], a 
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small case-control analysis from Australia [5], and a larger prospective cohort study, also 
from Australia [6]. The UK studies and the smaller Australian study did not find any 
significant hazard from exposure to cyanobacterial blooms in recreational waters, but the 
study by Pilotto et al [6] reported an increase in illness amongst those exposed to 
relatively low levels of cyanobacteria (>5,000 cells per mL) compared to unexposed 
individuals.  
 
Despite this limited and inconclusive evidence, the World Health Organization (WHO) 
Australia and several European countries have recommended guideline levels for 
recreational exposure to cyanobacteria [7 (pp.149-54), 8]. WHO guidelines present a 
three-tier approach, suggesting: 1) low probability of adverse health effects from waters 
with 20,000 cyanobacterial cells/mL or 10µg chlorophyll-a/L (if cyanobacteria are 
dominant); 2) moderate probability of adverse effects from waters with 100,000 cells/mL 
or 50µg chlorophyll-a/L; and 3) high probability of adverse effects from contact with 
and/or ingestion/aspiration of cyanobacteria at scum-forming densities [7 (p.150)]. There 
is concern, however, that the current management practice in some countries (such as 
Australia or Germany) of warning all users or closing access to waterbodies is overly 
proscriptive. Such practices can result in unease amongst regular users of recreational 
waters that are affected by cyanobacteria, and can impact communities surrounding these 
waters, which are important social and economic resources.  
 
Due to the small number of published epidemiology studies and the need for revision and 
refinement of recreational water exposure guidelines relating to planktonic cyanobacteria, 
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we conducted a prospective cohort study to investigate morbidity following recreational 
exposure to cyanobacteria. Specifically, we sought to: 1) quantify cyanotoxins in 
designated water recreation sites, and 2) assess the relationship between exposure to 
cyanobacteria and cyanotoxins in recreational waters and the incidence of reported 
symptoms. 
 
 
METHODS 
 
The study population of interest comprised adults and children engaging in recreational 
activities in enclosed waters (i.e. not marine waters) inhabited to varying degrees by 
planktonic cyanobacteria. Subjects were recruited over a three-year period from 1999 to 
2002 at water recreation sites in southern Queensland and the Myall Lakes area of New 
South Wales (Australia), and northeast and central Florida (USA). Recruitment was 
conducted on 54 separate days, mostly on weekends and holiday periods during the 
warmer months in order to maximise recruitment efficiency by concentrating on peak-use 
periods of recreational activity.  
 
Entry criteria into the study were twofold: 
• Engaging or planning to partake in water-contact activities in the study water body on 
the day of recruitment – ascertained by asking “Is anybody in the vehicle planning to 
go in the water and get wet here today?” 
• Able to be contacted by phone for follow-up. 
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 Study subjects were enrolled at the water sites and asked to complete a self-administered 
questionnaire before leaving for the day. They were also asked to submit to a telephone 
follow-up interview to be conducted as soon as practicable after three days from the day 
of enrolment. The interviewers asked to speak to study subjects within each household 
individually, i.e. proxy interviewees were discouraged. Exceptions were made in the case 
of children, where a parent or guardian was asked to decide whether or not their child 
would participate in the follow-up directly. 
 
The questionnaire, follow-up interview form and information letter are available in 
Stewart [9 (Appendix 1)]. The questionnaire gathered basic demographic data, 
information about relevant chronic conditions (chiefly allergies) and recent acute 
illnesses, as well as details of water-related activities. The follow-up interview elicited 
information about various acute illnesses, their onset and severity as well as smoking 
status, water exposure in the follow-up period and within-household grouping of study 
subjects. Interviewers and study subjects were more or less blinded to the exposure 
category of subjects at the time of the follow-up interview, as results of phytoplankton 
analyses were not available for several weeks after interviews were conducted. However, 
this incidental blinding did not apply to interviewers questioning subjects recruited from 
sites where cyanobacteria levels were obviously very high (from visual appearance of 
affected sites) or known to be low or absent.  
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Written permission (gatekeeper approval) from management authorities to recruit 
members of the public into this study was sought and secured for all sites listed in Table 
1. The study was approved by the University of Queensland’s Behavioural and Social 
Sciences Ethical Review Committee (clearance number B/168/SocPrevMed/99/PhD) and 
the University of Miami Human Subjects Committee (protocol number 02/031A). 
 
Table 1 lists the study sites, their location by region, a brief description of the site, and 
features peculiar to the site that distinguish them from other sites. Sites are also flagged 
according to their status as cyanobacteria-affected or cyanobacteria-free (i.e. reference) 
sites. Some sites that were initially identified as potential study sites on the basis of 
cyanobacteria monitoring programs were subsequently found to have low cyanobacteria 
measures at the time of subject recruitment, and were thus classified as reference sites. 
Two sites served as both study and reference sites due to variability in cyanobacterial 
densities over several recruitment visits. 
 
Water samples for phytoplankton and cyanotoxin analysis were collected by a modified 
grab sample method. Unused 1L (Queensland) or 150mL (NSW and Florida) 
polypropylene sample bottles were used to collect water at a depth of approximately 
70cm. The modification to the grab sample technique involved moving the sample bottle 
up and down in a vertical plane to sample water through the entire column in order to 
avoid spurious cyanobacteria estimates through sampling only surface water. 
Cyanobacteria surface scums can be widely distributed in the horizontal plane at the 
water surface, but are negligibly distributed vertically. Sampling only from the surface 
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during such bloom events would tend to overestimate recreational exposures, as the 
surface area of skin exposed to sub-surface water far exceeds the area exposed to the 
water surface when swimming or wading. In an attempt to address temporal and spatial 
heterogeneity of cyanobacteria profiles within each waterbody, samples were collected 
from between one and four locations on each recruitment day, depending on the size of 
the site. Samples were collected at two times: on arrival in the morning, and prior to 
departure in the afternoon. All samples were kept on ice, in darkness, and equal volumes 
were then pooled prior to leaving the site to form a composite sample. Composite samples 
were immediately fixed with Lugol’s iodine, and then stored at 40C until examined. 
Separate water samples were collected for cyanotoxin analysis; these samples were also 
stored at 40C but were not fixed. 
 
Sub-surface samples for faecal coliform analysis were collected in 250mL sterile 
containers shortly before departing each site; containers were immediately placed on ice, 
and then stored at 40C until analysed. Due to logistical issues, faecal coliforms were 
sampled only on days when a recruitment visit at a study site was followed by a routine 
working day. 
 
Total phytoplankton analyses were conducted at three separate laboratories due to 
contractual obligations of the various agencies that funded this work: Queensland Health 
Scientific Services, Brisbane (National Association of Testing Authorities [NATA] 
accredited) for all Queensland samples; Australian Water Technologies, Newcastle for all 
Myall Lakes area samples; CyanoLab, Palatka, Florida for all Florida samples. 
 10
 Cell identification and enumeration at these three centres were conducted by broadly 
similar methods, using a calibrated counting chamber with phase-contrast microscopy. 
Cell surface areas were determined by defining cyanobacteria cells as spherical or 
cylindrical, then measuring cell diameter (all cells) and length (idealised cylindrical 
cells). An appropriate number of cells were measured, and then averaged to give 
dimensions for each cyanobacterial taxon in each water sample. Surface areas were 
calculated using the formulas S.A. = 4πr2 (idealised spherical cells), or S.A. = 2(π r2) + 
(2π r)l (idealised cylindrical cells) where v = cell volume; r = cell radius; l = cell length; 
S.A. = cell surface area. Data for each cyanobacterial taxon were summed, and total 
cyanobacterial cell surface area was used as the measure of exposure for each recruitment 
day in subsequent statistical analyses.  
 
Samples that contained potentially toxic cyanobacteria were then analysed for specific 
cyanotoxins. Analysed toxins and their associated taxa were: 
• Microcystins : Microcystis spp, Anabaena spp, Planktothrix spp, 
• Saxitoxins (Australia only): Anabaena circinalis 
• Cylindrospermopsin: Cylindrospermopsis raciborskii, Aphanizomenon 
 ovalisporum 
• Anatoxin-a: (Florida only): Anabaena spp, C. raciborskii 
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Australian samples were analysed at Queensland Health Scientific Services laboratories. 
Saxitoxins were analysed by high performance liquid chromatography (HPLC) with 
fluorescence detection using a Shimadzu LC-10AVP system (Shimadzu Corp, Kyoto, 
Japan) based on the methods of Lawrence et al [10]; microcystins were measured by a 
Shimadzu LC-10A HPLC with photodiode array detection using the methods of Lawton 
et al [11]. Cylindrospermopsin was quantified by HPLC-MS/MS with a Perkin Elmer 
series 200 HPLC (Perkin Elmer Corp, Norwalk, CT, USA) coupled to a PE SCIEX API 
300 mass spectrometer (PE SCIEX, Concord, ON, Canada) [12]. In Florida, toxins were 
analysed at CyanoLab. Cylindrospermopsin and anatoxin-a were determined by a HPLC-
MS/MS method on a ThermoFinnigan LCQ Advantage system (ThermoFinnigan, San 
Jose, CA, USA). Microcystins were determined by an enzyme-linked immunosorbent 
assay method with a commercially available kit from Abraxis LLC (product # 520011, 
Abraxis LLC, Warminster, PA, USA).  
 
All faecal coliform samples were analysed within 24 hours following collection. Samples 
were analysed at the following laboratories: Queensland Health Scientific Services, 
Brisbane, QLD (NATA accredited): method # AS 4276.7 (Australian Standard method 
for thermotolerant coliforms and Escherichia coli – membrane filtration method); Centre 
for Integrated Environmental Protection, Griffith University, Brisbane, QLD: method # 
APHA 9222D (APHA membrane filtration method); Forster Environmental Laboratory, 
Forster, NSW (NATA accredited): method # APHA 9222D; Columbia Analytical 
Services, Jacksonville, Florida (NELAC accredited): method # SM 9222D (USEPA 
Standard Method – membrane filtration method).  
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 Water conductivity was measured at Australian study sites with an integrated 
conductivity/pH/temperature meter (Model WP-81, TPS P/L, Springwood, QLD, 
Australia). In Florida, conductivity was recorded with a DataSonde MP 6600 (YSI Inc, 
Yellow Springs, OH, USA).  
 
 
Data analysis 
Cyanobacterial cell surface area was chosen as the principal exposure variable of interest 
[9 (Chapter 3)] and classified as low (total cyanobacterial cell surface area <2.4mm2/mL), 
intermediate (2.4–12.0mm2/mL) and high (>12.0mm2/mL) based on guidelines from the 
Queensland Department of Natural Resources and Mines [9 (Chapter 3), 13]. Faecal 
coliform exposures were categorised as positive or negative according to the Australian 
and New Zealand regulatory guidelines for fresh and marine water quality [14]. Age was 
categorised into five age groups (see Table 2). Smoking status was categorised into three 
groups: active, passive and non-smokers. Passive smokers were defined as non-smokers 
or children aged less than 12 years who lived in a dwelling where at least one other 
household member smoked inside the house. Faecal coliform counts can fluctuate on a 
daily or weekly basis. Therefore analyses of symptom reporting using coliform data as 
exposure variables were conducted only on the sub-sets of the cohort for which these 
readings were available for the day of recruitment.  
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The dependent variable for all analyses was symptom reporting; symptoms were pooled 
into an “any symptom” category, and because of the disparate nature of symptoms 
associated with cyanobacteria exposure [1], reported symptoms were categorised as ear 
(sore ear/s; discharge from ear/s), eye (sore eye/s; eye redness; discharge from eye/s; 
itchy eye/s), gastro-intestinal (G-I) (vomiting; diarrhoea; abdominal pain; nausea), 
respiratory (difficulty breathing; dry cough; productive cough; runny nose; unusual 
sneezing; sore throat; wheezy breathing), cutaneous (skin rash; redness of the skin not 
related to sunburn; unusual itchiness), fever (single sign/symptom of fever) and the 
combined “any symptom” (any of the above). Respondents were asked to rate symptoms 
that occurred in the follow-up period as mild, moderate or severe. The number of 
symptoms reported as “severe” was, however, very low so this category was combined 
with “moderate”, to form a single “moderate or severe” category. Subjects were excluded 
from specific analyses if they reported one or more associated acute symptoms had 
started before recruitment into the study. 
 
Pearson’s chi-squared test and Fisher’s exact test were used to compare group 
proportions, where appropriate, while logistic regression was used to investigate 
associations between symptom variables and cyanobacterial exposure after accounting for 
potential confounding variables and geographic region, which was a design variable in all 
logistic regression models. A multivariable logistic regression main-effects model was 
then developed, using sequential backward elimination of non-significant variables 
(based on the model deviance statistic). Once the most parsimonious main-effects model 
was identified, all two-factor interactions were introduced into the model and stepwise 
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elimination of non-significant terms was undertaken (again based on the model deviance 
statistic) until the final model was obtained. The final model adjusted for age, sex, 
smoking and reported prior history of asthma, hay fever or eczema. A second 
multivariable model was developed for the “any symptoms” outcome by excluding 
subjects who reported exposure at the study waterbody in the five-day period prior to 
recruitment, as per the work of Pilotto et al [6]. SPSS v11.5 [15], Epi Info v6.O4d [16] 
and Stata/SE v8.0 [17] were used for statistical analyses and a significance level of 
α=0.05 was used to define statistical significance. 
 
 
RESULTS AND DISCUSSION 
The study entry criteria were met by 3,595 individuals; of these, 402 (11%) refused to 
participate in the study. Of the 3,193 people who accepted a questionnaire, 1,371 (43%) 
returned it. Of these, 40 individuals did not complete the follow-up interview for various 
reasons (uncontactable, refused to be interviewed, denied knowledge of the study). The 
1,331 subjects with follow-up data thus represented 42% of those who agreed to 
participate in the study by accepting a questionnaire. Demographic features of the cohort 
are shown in Table 2; the majority of participants were from Queensland, and most were 
less than 55 years of age and non-smokers. 
 
Table 3 presents the frequency (percentage) of subjects reporting symptoms at each level 
of cyanobacteria exposure. There were no significant differences between the frequency 
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or reported severity of symptoms over the three cyanobacteria exposure groups. For 
further analyses, we collapsed the symptom variables into two groups of “not reported” 
and “reported at any severity”. This dichotomisation also increased the robustness of the 
statistical modelling.  
 
Table 4 presents the results of crude and multivariable logistic modelling. Two 
statistically significant findings were identified: increased reporting of respiratory 
symptoms in the high cyanobacteria exposure group compared to the low group, odds 
ratio (OR) 2.1 (95% CI: 1.1, 4.0), and the pooled “any symptom” reporting was increased 
in the high cyanobacteria exposure group compared to the low exposure group, OR 1.7 
(95% CI: 1.0, 2.9). However, the significance of the latter result was not maintained with 
the exclusion of subjects with recent prior recreational water exposure, OR 1.6 (95% CI: 
0.8, 3.2).   
 
Analysis of cyanotoxin levels in study waters showed that these were infrequently seen 
and, when seen, at low levels. Microcystins were only detected on two occasions, at 
1μg/L (Doctors Lake) and 12μg/L (Lake Coolmunda); cylindrospermopsin was found on 
seven occasions (Lakes Wivenhoe, Somerset, Atkinson and Seminole), but the levels 
were low at 1μg/L and 2μg/L. Saxitoxins were not seen in this study, and anatoxin-a was 
only detected at one Florida site (Lake Seminole) on a single recruitment day, at 1μg/L. A 
statistically significant increase in symptom reporting amongst Florida subjects exposed 
to anatoxin-a was found by the Fisher-Freeman-Halton test (p=0.04), but the number of 
subjects exposed (n=18) was very low.  
 16
 No relationship between symptom reporting and faecal coliform counts in study waters 
was seen. Chi-squared tests comparing coliform levels and G-I symptoms (p=0.50), 
respiratory symptoms (p=0.92) and the pooled “any symptom” category (p=0.96) did not 
reveal any significant associations.  
 
The main findings of this work were that individuals exposed to recreational waters from 
which total cyanobacterial cell surface areas exceeded 12mm2/mL were more likely to 
report symptoms after exposure than those exposed to waters where cyanobacterial 
surface areas were less than 2.4mm2/mL. Reporting of respiratory symptoms was 
similarly associated with exposure to high levels of cyanobacteria. The measured effect 
size was similar but non-significant for reporting of ear and cutaneous symptoms, fever 
and all symptoms after exclusion of subjects with prior site exposure, which suggests that 
the sample sizes were too small to show significant differences between symptom rates at 
different levels of exposure within these categories. No relationship was detected between 
exposure to intermediate levels of cyanobacteria (total surface area 2.4–12.0 mm2/mL) 
and symptom reporting. 
 
The symptom category that appeared to be weighting the pooled “any symptom” category 
the most was that of respiratory symptoms, which itself showed a statistically significant 
increase in symptom reporting at high cyanobacterial exposures. However, from Table 3 
we see that respiratory symptom reporting was skewed towards the “mild” symptom 
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rating. Therefore, the conclusion that symptom reporting was higher in individuals 
exposed to high cyanobacteria levels compared to those exposed to low cyanobacteria 
levels must be tempered by the observation that mild respiratory symptoms appeared to 
be the dominant influence on overall symptom reporting. 
 
This study attempted to improve on some study design weaknesses of previously 
published work in this field. The control group was recruited at waters that were known 
or suspected to be substantially free of cyanobacteria. We were concerned that the control 
subjects (i.e. non-bathers) in the studies of Pilotto et al [6] and Philipp [2], Philipp & 
Bates [3] and Philipp et al [4] might differ in some way from those who chose to go in the 
water. They might also tend to under-report relevant illnesses, given the propensity of 
some people to give the kind of answers that they think health researchers are seeking 
[18]. There is a risk that some individuals who are non-bathers, when presented with 
questions that are obviously concerned with water-related activities, might tend to 
downplay symptoms that they correctly assume are unrelated to water contact and then 
incorrectly assume to be of no interest to researchers. 
 
We also measured cyanotoxins in study waters directly by HPLC-based methods. In 
previous studies cyanotoxins were either not considered or indirect and unquantified 
measures of cyanotoxin presence were used. However, the cyanotoxins were infrequently 
seen at study waters and, where seen, were at universally low levels. While we observed a 
significant increase in symptom reporting amongst Florida subjects exposed to anatoxin-
a, the number of subjects exposed was very low, so we were reluctant to draw any 
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conclusions from this finding. The infrequent presence and low concentrations of 
cyanotoxins in study waters highlights one of the disadvantages in conducting a 
prospective cohort study, that cyanobacteria and especially cyanotoxin levels are often 
dynamic and therefore unpredictable.   
 
We chose a biomass estimate – cell surface area – to determine exposure to 
cyanobacteria, rather than the traditional reporting method of cell counts per unit volume 
of water [9 (Chapter 3)]. Cyanobacteria cells can vary considerably in size, so measuring 
only cell counts will overestimate cyanobacterial biomass if picoplankton are dominant. 
Some workers recommend cyanobacterial biovolume or chlorophyll-a (if cyanobacteria 
dominate the phytoplankton profile) as estimates of cyanobacterial standing crop or for 
exposure guidelines [13, 19].  
 
The cohort was large enough to detect increased odds of symptom reporting in the “any 
symptom” and respiratory symptom categories amongst subjects exposed to high 
compared to low levels of cyanobacteria. Effects of similar magnitude were also seen for 
ear and skin symptoms and fever, as well as for symptom reporting after exclusion of 
subjects with recent prior exposure to study waters but these were not statistically 
significant. A larger sample size may have allowed us to confidently detect increased 
acute illness reporting from these symptom sub-groups. However, as this study essentially 
found only minor morbidity, the cost and effort required to conduct larger studies than 
this one would appear to outweigh the benefits.  
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 We did not see any dose-response relationships. With the exception of a non-significant 
O.R. for febrile illness there was no increased reporting of symptoms at intermediate 
exposure but an increase at high exposure. One explanation for this may be a threshold 
effect, i.e. a minimum level of exposure is needed in order to see an effect.  
 
This work was a study of exposures to non-toxic and potentially toxic cyanobacteria in 
recreational waters, but with essentially little or no exposure to known cyanotoxins. 
Recommendations arising from this work cannot, therefore, be applied to situations where 
cyanobacterial exotoxins are found to be in possibly hazardous concentrations. Using 
levels of toxin-producing cyanobacteria as indirect measures of cyanotoxin presence may 
overestimate the public health risks; exposure guidelines and management strategies that 
address the potential, not actual, presence of hazardous levels of cyanotoxins run the risk 
of propagating “warning fatigue”, where frequent or permanent advisories (see Figure 1) 
are ignored by a significant proportion of the public [9 (Appendix 2), 20].  
 
A more rigorous assessment of the risks will come with regularly updated knowledge of 
the actual cyanotoxin content in recreational waters. At present, this knowledge is only 
obtained from testing of water samples in specialist cyanotoxin laboratories, which is 
expensive and with a lag period measured in days. Research strategies directed at an 
inexpensive, in-situ test for cyanotoxins would be appropriate. We suggest that future 
work in this field should investigate the epidemiology of recreational exposure to known 
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cyanotoxins, rather than the epidemiology of recreational exposure to cyanobacteria per 
se. This would probably take the form of case-control studies in areas where cases could 
be identified (i.e. suitably distant from major cities). A retrospective cohort study may be 
appropriate if analytical turn-around times are sufficiently rapid to allow for the interview 
of visitors at cyanotoxin-affected campsites. School-based surveillance would also be 
appropriate in regions or towns – not cities – affected by future toxic blooms. There may 
also be helpful information to be gained from a more thorough questioning of suspect 
cases, especially with respect to reporting any history of allergy or atopy.  
 
When considering these results it is important to consider potential sources of error, 
particularly the possibilities of selection bias and confounding. Despite offering 
inducements (entry into a raffle for electronic goods, camping and boating permits) to 
increase participation in this study, the target population was inherently difficult to 
capture as most were healthy, young and busily engaged in leisure activities. The 
relatively low response rate (42%) means that the sample may become less representative 
of the wider population. The overall response rate also varied across the exposure groups 
with only 30% of eligible subjects returning questionnaires at high exposure sites 
compared to 43% and 44% of those at intermediate and low cyanobacteria sites 
respectively (p<0.001). This difference was due to a particularly poor response from high 
exposure sites in Florida (27%). Some peculiar features of these sites in Florida probably 
contributed to the response rate, e.g. lack of swimming beaches (resulting in over-
reliance on subjects using powered watercraft) and increased demand for limited parking 
spaces (manifested by boat-user etiquette for rapid site entry and egress, with 
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subsequently reduced priority for completing questionnaires)[9 (Appendix 2)]. However, 
assuming that those who failed to return questionnaires were no more or less likely to go 
on to develop symptoms than those who participated then, after adjusting for study 
region, the effect estimates should not be affected.  
 
Because nuisance and potentially harmful cyanobacteria are cosmopolitan in distribution, 
and exposure guidelines should therefore be universal, not region specific, we combined 
the data from all three regions (Queensland, NSW and Florida). Overall, 80% of highly 
exposed subjects but only 10% of the low exposure group came from Florida. In addition, 
symptom reporting was considerably lower among Florida respondents than in Australia 
(OR for all symptoms = 0.6, 95%CI: 0.4, 1.1 for Florida and 0.9, 95%CI: 0.6, 1.3 for 
NSW compared to Queensland). Although we adjusted for region in our analyses, any 
residual confounding by this variable is likely to have weakened the true association. Of 
note, when we adjusted for important factors in our multivariable models, the symptom 
effect sizes associated with cyanobacteria exposure were strengthened slightly, 
suggesting that the associations seen are unlikely to be due to confounding. Although it is 
impossible to rule out other unknown confounders these would have to be strongly 
associated with both exposure and symptoms in order to completely explain the effects. 
We believe it unlikely that such strong confounders exist, nonetheless the possibility 
remains that unmeasured confounding variables may explain our findings. 
 
 
CONCLUSIONS 
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This study has shown that subjects exposed to high levels of cyanobacteria in recreational 
waters, as measured by total cell surface area, were more likely to report symptoms 
following such exposure than subjects exposed to low levels of cyanobacteria. 
Respiratory symptoms were most evident, and the reported severity of symptoms across 
all groups was low. In the present study levels of cyanotoxins in recreational waterbodies 
affected by cyanobacteria blooms were universally low. Further work quantifying the 
relationship between cyanotoxin levels and health outcomes should be considered. The 
potential remains for significant morbidity and mortality associated with recreational 
exposure to cyanotoxins, these being highly potent water-soluble toxins.  
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Figure legend: 
 
 Figure. Example of an Australian cyanobacteria warning sign 
posted at a recreational water site (with a concise, eloquent but 
anonymous critique of the message?). 
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Table 1. Recreational waters visited for recruitment of study subjects 
 
SITE REGION DESCRIPTION POWERED 
WATERCRAFT 
PECULIAR 
FEATURES 
(S)TUDY OR 
(R)EFERENCE SITE 
     PLANNED ACTUAL 
Logan Inlet 
– Lake 
Wivenhoe 
South-east 
Queensland 
Large water-supply 
storage 
No  S S + R 
Kirkleagh – 
Lake 
Somerset 
South-east 
Queensland 
Large water-supply 
storage 
Yes  S R 
The Spit – 
Lake 
Somerset 
South-east 
Queensland 
Large water-supply 
storage 
Yes  S S + R 
Brown 
Lake – Nth 
Stradbroke 
Island 
South-east 
Queensland 
Small dune lake No Acidic perched 
lake (pH 4.6 – 
4.7) 
R R 
Atkinson 
Dam 
South-east 
Queensland 
Small irrigation 
storage 
Yes  S S 
Natural 
Arch 
South-east 
Queensland 
Upper catchment 
stream 
No Water 
temperature 
lowest of all 
sites 
R R 
College’s 
Crossing 
South-east 
Queensland 
Shallow river – 
release water from 
Wivenhoe Dam 
No Dairy farms in 
catchment – 
faecal coliform 
counts often 
high 
R R 
Currumbin 
Rock Pool 
South-east 
Queensland 
Lower catchment 
stream 
No  R R 
Bombah 
Broadwater 
Myall Lakes 
NSW 
Large saline enclosed 
lake 
Yes  S R 
Myall Lake Myall Lakes 
NSW 
Large brackish water 
lake 
No  S S 
Smith’s 
Lake 
Myall Lakes 
NSW 
Small saline enclosed 
lake 
Yes  R R 
Lake 
Coolmunda 
Southern 
Queensland 
Small irrigation 
storage 
Yes  S S 
Hickory 
Point – 
Little Lake 
Harris 
Central 
Florida 
Chain of connected 
inland lakes 
Yes  S S 
Manatee 
Springs 
North/central 
Florida 
Freshwater spring 
bulkhead 
No  R R 
Fanning 
Springs 
North/central 
Florida 
Freshwater spring 
bulkhead 
No  R R 
Lake 
Seminole 
West/central 
Florida 
Artificial lake in 
densely developed 
area 
Yes  S S 
Doctors 
Lake 
North-east 
Florida 
Tidal influenced 
tributary lake of the 
St Johns River 
Yes  S S 
Lake 
Cannon 
Central 
Florida 
Small urban lake Yes  S S 
Lake Shipp Central 
Florida 
Small urban lake Yes  S S 
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Table 2. Demographic characteristics of the entire study cohort. 
 
 n (%) 
<12 312 (23) 
13-24 346 (26) 
25-39 375 (28) 
40-54 256 (19) 
Age (years)
>55 42 (3) 
 
Female 635 (48) Sex
Male 696 (52) 
 
Florida 216 (16) 
New South Wales 300 (23) 
Region
Queensland 815 (61) 
 
Non smoker 953 (72) 
Passive smoker 131 (10) 
Smoking status
Smoker 247 (19) 
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Table 3. Frequency (percentage) of subjects reporting symptoms against level of 
cyanobacteria exposure: low (cell surface area <2.4mm2/mL), medium (2.4 – 12.0mm2/mL) 
and high (>12.0mm2/mL).  
 
Cyanobacteria exposure  Symptoms 
Low 
n (%) 
Medium 
n (%) 
High 
n (%) p-value 
Any symptom  0.42 
None 569 (70) 134 (74) 99 (67) 
Mild 147 (18) 28 (16) 34 (23) 
 
Moderate/severe 94 (12) 18 (10) 14 (10) 
 
Ear symptoms  0.75 
None 895 (96) 199 (98) 159 (96) 
Mild 21 (2) 3 (2) 4 (2) 
 
Moderate/severe 12 (1) 1 (1) 3 (2) 
 
Eye symptoms  0.75 
None 872 (94) 196 (95) 154 (95) 
Mild 41 (4) 5 (2) 6 (4) 
 
Moderate/severe 18 (2) 5 (2) 3 (2) 
 
Gastro-intestinal symptoms  0.89 
None 871 (94) 199 (95) 158 (95) 
Mild 30 (3) 5 (2) 5 (3) 
 
Moderate/severe 27 (3) 5 (2) 3 (2) 
 
Respiratory symptoms  0.57 
None 691 (86) 169 (88) 122 (82) 
Mild 87 (11) 19 (10) 22 (15) 
 
Moderate/severe 29 (4) 5 (3) 5 (3) 
 
Cutaneous symptoms  0.52 
None 875 (95) 197 (96) 159 (96) 
Mild 23 (3) 6 (3) 6 (4) 
 
Moderate/severe 20 (2) 2 (1) 1 (1) 
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Table 4. Frequency (percentage) and binary logistic regression estimates of crude and multivariable O.R. 
and associated 95% confidence intervals (95% CI). 
 
Exposure Symptoms   
None Present Crude models2 Multivariable3
 
Cyanobacterial cell 
surface area1 n (%) n (%) O.R. (95% CI) O.R. (95% CI) 
 
Low 569 (70) 241 (30) 1 1 
Intermediate 134 (74) 46 (26) 0.8 (0.6, 1.2) 0.8 (0.6, 1.3) 
Any symptom 
High 99 (67) 48 (33) 1.6 (1.0, 2.7) 1.7 (1.0, 2.9) 
 
Low 895 (96) 33 (4) 1 1 
Intermediate 199 (98) 4 (2) 0.6 (0.2, 1.5) 0.5 (0.2, 1.5) 
Ear symptoms 
High 159 (96) 7 (4) 1.9 (0.6, 6.5) 2.0 (0.6, 7.1) 
 
Low 872 (94) 59 (6) 1 1 
Intermediate 196 (95) 10 (5) 0.8 (0.4, 1.8) 0.8 (0.4, 1.9) 
Eye symptoms 
High 154 (95) 9 (6) 0.6 (0.2, 1.6) 0.6 (0.3, 1.7) 
 
Low 871 (94) 57 (6) 1 1 
Intermediate 199 (95) 10 (5) 0.9 (0.4, 1.7) 0.9 (0.4, 1.8) 
G-I symptoms 
High 158 (95) 8 (5) 0.9 (0.3, 2.2) 0.9 (0.4, 2.2) 
 
Low 691 (86) 116 (14) 1 1 
Intermediate 169 (88) 24 (12) 1.0 (0.6, 1.6) 0.9 (0.6, 1.6) 
Respiratory symptoms 
High 122 (82) 27 (18) 2.0 (1.1, 3.7) 2.1 (1.1, 4.0) 
 
Low 875 (95) 43 (5) 1 1 
Intermediate 197 (96) 8 (4) 0.7 (0.3, 1.7) 0.7 (0.3, 1.8) 
Cutaneous symptoms 
High 159 (96) 7 (4) 1.9 (0.9, 4.3) 1.9 (0.9, 4.4) 
 
Low 938 (99) 10 (1) 1 1 
Intermediate 208 (99) 3 (1) 1.5 (0.4, 5.6) 1.8 (0.5, 6.7) 
Fever 
High 165 (99) 2 (1) 2.0 (0.5, 8.7) 1.8 (0.4, 8.1) 
 
Low 436 (67) 200 (31) 1 1 
Intermediate 74 (69) 33 (31) 0.9 (0.6, 1.5) 0.9 (0.6, 1.5) 
Any symptom – after exclusion of 
subjects with recent (5 days prior to 
recruitment) exposure High 71 (69) 32 (31) 1.5 (0.8, 2.9) 1.6 (0.8, 3.2) 
1: Low = <2.4mm2/mL; Intermediate = 2.4 – 12.0mm2/mL; High = >12.0mm2/mL 
2: Adjusted for geographic region (QLD, NSW, Florida) as a design variable and clustered by household  
3: Adjusted for geographic region (QLD, NSW, Florida), age-group, sex, smoking and reported prior history of  
   asthma, hay fever or eczema, and clustered by household 
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